Statement of Changes in Beneficial Ownership (4)
05 Abril 2022 - 3:35PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Langley LaTanya |
2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co
[
EPC
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Legal Officer |
(Last)
(First)
(Middle)
C/O EDGEWELL PERSONAL CARE COMPANY, 6 RESEARCH DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
4/1/2022 |
(Street)
SHELTON, CT 06484
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Non-Qualified Stock Options 4/1/2022 | $36.77 | 4/1/2022 | | A | | 5031 | | 11/12/2022 (1) | 4/1/2032 | Common Stock | 5031 | $0.00 | 5031 | D | |
Restricted Stock Equivalents 4/1/2022 | $0.00 | 4/1/2022 | | A | | 2652 | | 11/12/2022 (2) | (2) | Common Stock | 2652 | $0.00 | 2652 | D | |
Restricted Stock Equivalents 4-1-2022 | $0.00 | 4/1/2022 | | A | | 9519 | | 4/1/2023 (3) | (3) | Common Stock | 9519 | $0.00 | 9519 | D | |
Performance Restricted Stock Equivalents 4/1/2022 | $0.00 | 4/1/2022 | | A | | 8839 | | 11/12/2024 (4) | (4) | Common Stock | 8839 | $0.00 | 8839 | D | |
Explanation of Responses: |
(1) | One-third of the Options will become exercisable on each of 11/12/2022, 11/12/2023 and 11/12/2024, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. |
(2) | One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/12/2022, 11/12/2023 and 11/12/2024 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. |
(3) | One-half of the RSEs will vest and convert into shares of Edgewell common stock on each of 4/1/2023 and 4/1/2024 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. |
(4) | The PRSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2024 if the following specified performance criteria is met: Relative Total Shareholder Return for the "Performance Period" beginning on October 1, 2021 and ending on September 30, 2024 (100%). Percentage will range from 0% to 100% based on company performance. The amount shown is the maximum amount available to vest. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Langley LaTanya C/O EDGEWELL PERSONAL CARE COMPANY 6 RESEARCH DRIVE SHELTON, CT 06484 |
|
| Chief Legal Officer |
|
Signatures
|
LaTanya Langley | | 4/1/2022 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Edgewell Personal Care (NYSE:EPC)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Edgewell Personal Care (NYSE:EPC)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024